• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对健康志愿者急性给予大麻素CB1拮抗剂利莫那班会损害其积极情感记忆。

Acute administration of the cannabinoid CB1 antagonist rimonabant impairs positive affective memory in healthy volunteers.

作者信息

Horder Jamie, Cowen Philip J, Di Simplicio Martina, Browning Michael, Harmer Catherine J

机构信息

University Department of Psychiatry, Warneford Hospital, University of Oxford, Oxford, UK.

出版信息

Psychopharmacology (Berl). 2009 Jul;205(1):85-91. doi: 10.1007/s00213-009-1517-4. Epub 2009 Apr 1.

DOI:10.1007/s00213-009-1517-4
PMID:19337726
Abstract

BACKGROUND

Emotional processing measures are sensitive to acute administration of clinically useful antidepressant drugs. We wished to test the hypothesis that these models would also be able to detect agents likely to cause depression as an adverse effect. The anti-obesity drug and cannabinoid type 1 receptor antagonist, rimonabant, is associated with significant rates of depression and anxiety in clinical use.

MATERIALS AND METHODS

Thirty healthy adult volunteers were randomly assigned to receive a single dose of rimonabant (20 mg) or lactose placebo in a double-blind, between-groups design. Three hours after medication administration, subjects undertook an emotional processing test battery including facial emotion recognition, emotional word attentional dot probe, self-relevant word classification, emotional and declarative memory and the emotion-potentiated acoustic startle response. Subjective state was assessed via self-report measures.

RESULTS

A single dose of rimonabant did not alter subjective mood. However, rimonabant selectively reduced incidental recall of positive self-relevant adjectives, an effect contrary to that seen following the administration of antidepressants. There were no effects of rimonabant on the other measures of emotional processing.

CONCLUSIONS

These results suggest that a single dose of rimonabant decreases positive emotional memory in the absence of changes in subjective state. Further studies are required to examine whether rimonabant might produce a wider range of negative emotional biases with repeated treatment.

摘要

背景

情绪加工测量对临床上有用的抗抑郁药物的急性给药敏感。我们希望检验这样一个假设,即这些模型也能够检测出可能导致抑郁作为不良反应的药物。抗肥胖药物和大麻素1型受体拮抗剂利莫那班在临床使用中与显著的抑郁和焦虑发生率相关。

材料与方法

30名健康成年志愿者被随机分配,在双盲组间设计中接受单剂量利莫那班(20毫克)或乳糖安慰剂。给药三小时后,受试者进行了一系列情绪加工测试,包括面部情绪识别、情绪词汇注意力点探测、自我相关词汇分类、情绪和陈述性记忆以及情绪增强的听觉惊吓反应。通过自我报告测量评估主观状态。

结果

单剂量利莫那班未改变主观情绪。然而,利莫那班选择性地降低了对积极自我相关形容词的偶然回忆,这一效果与服用抗抑郁药后的情况相反。利莫那班对其他情绪加工测量没有影响。

结论

这些结果表明,单剂量利莫那班在主观状态无变化的情况下会降低积极情绪记忆。需要进一步研究来检验利莫那班在重复治疗时是否可能产生更广泛的负面情绪偏差。

相似文献

1
Acute administration of the cannabinoid CB1 antagonist rimonabant impairs positive affective memory in healthy volunteers.对健康志愿者急性给予大麻素CB1拮抗剂利莫那班会损害其积极情感记忆。
Psychopharmacology (Berl). 2009 Jul;205(1):85-91. doi: 10.1007/s00213-009-1517-4. Epub 2009 Apr 1.
2
Effects of 7 days of treatment with the cannabinoid type 1 receptor antagonist, rimonabant, on emotional processing.7 天治疗大麻素 1 型受体拮抗剂利莫那班对情绪处理的影响。
J Psychopharmacol. 2012 Jan;26(1):125-32. doi: 10.1177/0269881111400649. Epub 2011 Mar 15.
3
Short-term NK1 receptor antagonism and emotional processing in healthy volunteers.短期 NK1 受体拮抗作用与健康志愿者的情绪处理。
Psychopharmacology (Berl). 2011 May;215(2):239-46. doi: 10.1007/s00213-010-2133-z. Epub 2010 Dec 15.
4
Peripheral selectivity of the novel cannabinoid receptor antagonist TM38837 in healthy subjects.新型大麻素受体拮抗剂 TM38837 在健康受试者中的外周选择性。
Br J Clin Pharmacol. 2013 Dec;76(6):846-57. doi: 10.1111/bcp.12141.
5
Effects of the cannabinoid CB1 receptor antagonist rimonabant in models of emotional reactivity in rodents.大麻素CB1受体拮抗剂利莫那班对啮齿动物情绪反应模型的影响。
Biol Psychiatry. 2005 Feb 1;57(3):261-7. doi: 10.1016/j.biopsych.2004.10.032.
6
Increased positive versus negative affective perception and memory in healthy volunteers following selective serotonin and norepinephrine reuptake inhibition.在选择性5-羟色胺和去甲肾上腺素再摄取抑制后,健康志愿者的积极情感感知和记忆相对于消极情感感知和记忆有所增强。
Am J Psychiatry. 2004 Jul;161(7):1256-63. doi: 10.1176/appi.ajp.161.7.1256.
7
Early effects of mirtazapine on emotional processing.米氮平对情绪加工的早期影响。
Psychopharmacology (Berl). 2009 May;203(4):685-91. doi: 10.1007/s00213-008-1410-6. Epub 2008 Nov 25.
8
Reduced neural response to reward following 7 days treatment with the cannabinoid CB1 antagonist rimonabant in healthy volunteers.健康志愿者接受大麻素 CB1 拮抗剂利莫那班治疗 7 天后,对奖励的神经反应降低。
Int J Neuropsychopharmacol. 2010 Sep;13(8):1103-13. doi: 10.1017/S1461145710000453. Epub 2010 Apr 29.
9
Dissociable effects of acute antidepressant drug administration on subjective and emotional processing measures in healthy volunteers.急性给予抗抑郁药物对健康志愿者主观及情绪加工指标的分离效应。
Psychopharmacology (Berl). 2008 Sep;199(4):495-502. doi: 10.1007/s00213-007-1058-7. Epub 2008 Jun 25.
10
Effects of cannabinoid CB1 receptor antagonist rimonabant in consolidation and reconsolidation of methamphetamine reward memory in mice.大麻素CB1受体拮抗剂利莫那班对小鼠甲基苯丙胺奖赏记忆巩固和再巩固的影响。
Psychopharmacology (Berl). 2009 Jun;204(2):203-11. doi: 10.1007/s00213-008-1450-y. Epub 2009 Jan 16.

引用本文的文献

1
Effects of 28-day simvastatin administration on emotional processing, reward learning, working memory, and salivary cortisol in healthy participants at-risk for depression: OxSTEP, an online experimental medicine trial.28天服用辛伐他汀对有抑郁症风险的健康参与者情绪加工、奖赏学习、工作记忆及唾液皮质醇的影响:OxSTEP,一项在线实验性医学试验
Psychol Med. 2025 May 22;55:e155. doi: 10.1017/S0033291725001187.
2
Probiotics reduce negative mood over time: the value of daily self-reports in detecting effects.随着时间的推移,益生菌可减轻负面情绪:日常自我报告在检测效果方面的价值。
Npj Ment Health Res. 2025 Apr 9;4(1):10. doi: 10.1038/s44184-025-00123-z.
3

本文引用的文献

1
Dissociable effects of acute antidepressant drug administration on subjective and emotional processing measures in healthy volunteers.急性给予抗抑郁药物对健康志愿者主观及情绪加工指标的分离效应。
Psychopharmacology (Berl). 2008 Sep;199(4):495-502. doi: 10.1007/s00213-007-1058-7. Epub 2008 Jun 25.
2
Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials.减肥药物利莫那班的疗效与安全性:随机试验的荟萃分析
Lancet. 2007 Nov 17;370(9600):1706-13. doi: 10.1016/S0140-6736(07)61721-8.
3
Cognitive reactivity to sad mood provocation and the prediction of depressive relapse.
Controlled Inhalation of Tetrahydrocannabinol-Predominant Cannabis Flos Mitigates Severity of Post-Traumatic Stress Disorder Symptoms and Improves Quality of Sleep and General Mood in Cannabis-Experienced UK Civilians: A Real-World, Observational Study.
对以四氢大麻酚为主的大麻花朵进行控制性吸入可减轻有大麻使用经历的英国平民创伤后应激障碍症状的严重程度,并改善睡眠质量和总体情绪:一项真实世界的观察性研究。
Med Cannabis Cannabinoids. 2024 Aug 28;7(1):149-159. doi: 10.1159/000540978. eCollection 2024 Jan-Dec.
4
Neuropsychological Effects of Antidepressants: Translational Studies.抗抑郁药的神经心理学效应:转化研究。
Curr Top Behav Neurosci. 2024;66:101-130. doi: 10.1007/7854_2023_446.
5
Curcumin in Depression: Potential Mechanisms of Action and Current Evidence-A Narrative Review.姜黄素与抑郁症:潜在作用机制及当前证据——一篇叙述性综述
Front Psychiatry. 2020 Nov 27;11:572533. doi: 10.3389/fpsyt.2020.572533. eCollection 2020.
6
Druggable Targets in Endocannabinoid Signaling.内源性大麻素信号传导中的可药物靶标
Adv Exp Med Biol. 2020;1274:177-201. doi: 10.1007/978-3-030-50621-6_8.
7
Meet Your Stress Management Professionals: The Endocannabinoids.遇见你的压力管理专家:内源性大麻素。
Trends Mol Med. 2020 Oct;26(10):953-968. doi: 10.1016/j.molmed.2020.07.002. Epub 2020 Aug 28.
8
Cognitive neuropsychological theory of antidepressant action: a modern-day approach to depression and its treatment.抗抑郁药作用的认知神经心理学理论:一种现代的抑郁症及其治疗方法。
Psychopharmacology (Berl). 2021 May;238(5):1265-1278. doi: 10.1007/s00213-019-05448-0. Epub 2020 Jan 15.
9
An endocannabinoid receptor polymorphism modulates affective processing under stress.一种内源性大麻素受体多态性调节应激下的情感处理。
Soc Cogn Affect Neurosci. 2018 Nov 8;13(11):1177-1189. doi: 10.1093/scan/nsy083.
10
Using the affective bias test to predict drug-induced negative affect: implications for drug safety.使用情感偏见测试预测药物引起的负面情绪:对药物安全性的影响。
Br J Pharmacol. 2017 Oct;174(19):3200-3210. doi: 10.1111/bph.13972. Epub 2017 Aug 30.
对悲伤情绪激发的认知反应与抑郁复发的预测
Arch Gen Psychiatry. 2006 Jul;63(7):749-55. doi: 10.1001/archpsyc.63.7.749.
4
Antidepressant drug treatment modifies the neural processing of nonconscious threat cues.抗抑郁药物治疗可改变对非意识威胁线索的神经处理过程。
Biol Psychiatry. 2006 May 1;59(9):816-20. doi: 10.1016/j.biopsych.2005.10.015. Epub 2006 Feb 7.
5
Effects of the cannabinoid CB1 receptor antagonist rimonabant in models of emotional reactivity in rodents.大麻素CB1受体拮抗剂利莫那班对啮齿动物情绪反应模型的影响。
Biol Psychiatry. 2005 Feb 1;57(3):261-7. doi: 10.1016/j.biopsych.2004.10.032.
6
Inverse agonism and neutral antagonism at cannabinoid CB1 receptors.大麻素CB1受体的反向激动作用和中性拮抗作用。
Life Sci. 2005 Feb 4;76(12):1307-24. doi: 10.1016/j.lfs.2004.10.025. Epub 2004 Dec 8.
7
Cannabinoid inhibition improves memory in food-storing birds, but with a cost.大麻素抑制作用可改善储食鸟类的记忆,但有一定代价。
Proc Biol Sci. 2004 Oct 7;271(1552):2043-8. doi: 10.1098/rspb.2004.2823.
8
SR141716A, a cannabinoid CB1 receptor antagonist, improves memory in a delayed radial maze task.SR141716A,一种大麻素CB1受体拮抗剂,可改善延迟放射状迷宫任务中的记忆。
Eur J Pharmacol. 2003 Sep 23;477(3):213-7. doi: 10.1016/j.ejphar.2003.08.025.
9
Toward a neuropsychological theory of antidepressant drug action: increase in positive emotional bias after potentiation of norepinephrine activity.迈向抗抑郁药物作用的神经心理学理论:去甲肾上腺素活性增强后积极情绪偏向增加。
Am J Psychiatry. 2003 May;160(5):990-2. doi: 10.1176/appi.ajp.160.5.990.
10
SR 141716A enhances spatial memory as assessed in a radial-arm maze task in rats.
Eur J Pharmacol. 2000 Sep 15;404(1-2):175-9. doi: 10.1016/s0014-2999(00)00615-4.